Improve Clinical Trial Outcomes, Mitigate Study Costs

With the rise in precision medicine, clinical trial protocols and post-market programs have become increasingly more complex. This complexity presents challenges in the design of clinical trials that include genetic components, but also the opportunity to uncover greater value in the process through a proper genetic focus.

InformedDNA genetics expertise for clinical trialsFurther, as the focus of clinical research increasingly shifts toward rare and orphan diseases, as well as greater personalization, patient recruitment becomes a significant challenge: How do you find and engage the right patients to participate in these studies? Obviously, trial sponsors and clinical research sites must harness the power of genetic information. But first, they must access the expertise and infrastructure to collect that genetic information, and then apply it to enhance and manage different methods of recruitment

Whether it is helping develop programs, facilitating genetic testing, patient identification, patient engagement, or conducting genetic counseling, our unparalleled team of genetics experts are experienced in working with leading pharmaceutical companies and contract research organizations to develop and implement genetics-informed strategies for clinical trials.

Learn more about how we help clinical trial sponsors and CROs improve outcomes and mitigate costs in this case study.

Let’s talk about how we can help incorporate genetics into your trial or study – just submit the form below and we’ll get in touch quickly.